STE · Steris PLC - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.50B | $1.46B | $1.39B | $1.28B | $1.37B | $1.33B | $1.28B | $1.40B | $1.34B | $1.16B |
| Cost of Revenue | $840.70M | $814.40M | $763.10M | $707.07M | $760.24M | $750.12M | $711.08M | $793.05M | $748.83M | $542.14M |
| Gross Profit | $655.50M | $645.90M | $628.00M | $572.43M | $610.33M | $578.79M | $573.46M | $602.59M | $593.53M | $517.80M |
| R&D | $29.50M | $28.20M | $26.40M | $25.57M | $27.36M | $27.03M | $25.50M | $25.91M | $27.04M | $24.75M |
| SG&A | $352.30M | $349.70M | $353.80M | $335.63M | $335.45M | $329.30M | $359.06M | $360.52M | $380.65M | $334.63M |
| Total Operating Expenses | $382.30M | $380.10M | $382.00M | $386.90M | $365.04M | $359.13M | $384.58M | $386.44M | $407.67M | $359.40M |
| D&A | - | - | $119.40M | $112.70M | - | - | $137.93M | - | - | $138.86M |
| Operating Income | $273.20M | $265.80M | $246.00M | $185.53M | $245.29M | $219.67M | $188.88M | $216.16M | $185.86M | $158.40M |
| Interest Expense | $14.90M | $14.90M | $30.40M | $30.38M | $19.09M | $36.94M | $32.36M | $38.95M | $36.94M | $22.67M |
| Income Tax | $63.50M | $60.60M | $53.90M | $35.31M | $55.38M | $43.51M | $34.12M | $38.34M | $33.81M | $24.20M |
| Net Income | $192.90M | $191.90M | $177.40M | $145.40M | $173.53M | $150.03M | $123.55M | $140.74M | $115.32M | $111.26M |
| EPS - Basic | $1.96 | $1.95 | $1.80 | $1.47 | $1.76 | $1.52 | $1.25 | $1.42 | $1.17 | $1.11 |
| EPS - Diluted | $1.96 | $1.94 | $1.79 | $1.46 | $1.75 | $1.51 | $1.25 | $1.42 | $1.16 | $1.10 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $423.70M | $319.20M | $279.70M | $207.02M | $155.18M | $172.19M | $208.61M | $195.59M | $213.76M | $348.32M |
| Accounts Receivable | $990.60M | $947.30M | $947.10M | $1.04B | $915.20M | $923.34M | $1.01B | $964.02M | $940.33M | $928.32M |
| Inventory | $673.50M | $658.50M | $641.20M | $581.33M | $649.56M | $688.93M | $674.53M | $855.62M | $821.13M | $695.49M |
| Accounts Payable | $285.10M | $308.90M | $300.90M | $280.77M | $238.30M | $235.07M | $251.72M | $276.73M | $293.63M | $279.62M |
| Current Assets | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B | $2.87B | $2.22B | $2.17B | $2.01B |
| Total Assets | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $11.06B | $11.44B | $11.28B | $10.82B |
| Current Liabilities | $922.30M | $888.90M | $926.60M | $1.02B | $891.12M | $805.48M | $931.13M | $913.69M | $873.12M | $861.84M |
| Long-term Debt | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B | $3.12B | $3.23B | $3.37B | $3.02B |
| Total Liabilities | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B | $4.75B | $5.01B | $5.09B | $4.73B |
| Stockholders' Equity | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B | $6.30B | $6.42B | $6.18B | $6.08B |
| Retained Earnings | $2.86B | $2.73B | $2.60B | $2.48B | $2.39B | $2.27B | $2.09B | $2.13B | $2.05B | $1.91B |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $420.00M | $303.74M | - | - | $281.13M | - | - | $231.75M |
| Investing Cash Flow | - | - | ($108.50M) | $687.83M | - | - | ($66.60M) | - | - | ($109.42M) |
| Financing Cash Flow | - | - | ($213.10M) | ($998.93M) | - | - | ($213.64M) | - | - | ($141.41M) |
| CapEx | - | - | $93.60M | $108.08M | - | - | $66.60M | - | - | $115.93M |
| Free Cash Flow | - | - | $326.40M | $195.66M | - | - | $214.53M | - | - | $115.81M |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 43.8% | 44.2% | 45.1% | 44.7% | 44.5% | 43.6% | 44.6% | 43.2% | 44.2% | 44.8% |
| Operating margin | 18.3% | 18.2% | 17.7% | 14.5% | 17.9% | 16.5% | 14.7% | 15.5% | 13.8% | 13.7% |
| EBITDA margin | - | - | 26.3% | 23.3% | - | - | 25.4% | - | - | 25.7% |
| Net margin | 12.9% | 13.1% | 12.8% | 11.4% | 12.7% | 11.3% | 9.6% | 10.1% | 8.6% | 9.6% |
| Free cash flow margin | - | - | 23.5% | 15.3% | - | - | 16.7% | - | - | 10.0% |
| FCF / Net income | - | - | 1.84 | 1.35 | - | - | 1.74 | - | - | 1.04 |
| R&D / Revenue | 2.0% | 1.9% | 1.9% | 2.0% | 2.0% | 2.0% | 2.0% | 1.9% | 2.0% | 2.1% |
| SG&A / Revenue | 23.5% | 23.9% | 25.4% | 26.2% | 24.5% | 24.8% | 28.0% | 25.8% | 28.4% | 28.9% |
| Effective tax rate | 24.8% | 24.0% | 23.3% | 19.5% | 24.2% | 22.5% | 21.6% | 21.4% | 22.7% | 17.9% |
| Return on assets | 1.8% | 1.8% | 1.7% | 1.4% | 1.7% | 1.5% | 1.1% | 1.2% | 1.0% | 1.0% |
| Return on equity | 2.7% | 2.7% | 2.5% | 2.2% | 2.7% | 2.3% | 2.0% | 2.2% | 1.9% | 1.8% |
| Return on invested capital | 2.3% | 2.3% | 2.1% | 1.8% | 2.2% | 1.9% | 1.6% | 1.8% | 1.5% | 1.4% |
| Liquidity | ||||||||||
| Current ratio | 2.48 | 2.37 | 2.22 | 1.96 | 2.13 | 2.41 | 3.08 | 2.43 | 2.49 | 2.33 |
| Quick ratio | 1.75 | 1.63 | 1.53 | 1.39 | 1.40 | 1.55 | 2.36 | 1.49 | 1.55 | 1.53 |
| Cash ratio | 0.46 | 0.36 | 0.30 | 0.20 | 0.17 | 0.21 | 0.22 | 0.21 | 0.24 | 0.40 |
| Leverage | ||||||||||
| Debt / Equity | 0.27 | 0.27 | 0.27 | 0.29 | 0.32 | 0.33 | 0.50 | 0.50 | 0.54 | 0.50 |
| Debt / Assets | 0.18 | 0.18 | 0.18 | 0.19 | 0.20 | 0.21 | 0.28 | 0.28 | 0.30 | 0.28 |
| Debt / EBITDA | - | - | 5.21 | 6.43 | - | - | 9.55 | - | - | 10.16 |
| Interest coverage | 18.3x | 17.8x | 8.1x | 6.1x | 12.8x | 5.9x | 5.8x | 5.6x | 5.0x | 7.0x |
| Equity multiplier | 1.48 | 1.49 | 1.50 | 1.54 | 1.56 | 1.55 | 1.76 | 1.78 | 1.83 | 1.78 |
| Liabilities / Assets | 0.32 | 0.33 | 0.33 | 0.35 | 0.36 | 0.35 | 0.43 | 0.44 | 0.45 | 0.44 |
| Efficiency | ||||||||||
| Asset turnover | 0.14 | 0.14 | 0.13 | 0.13 | 0.14 | 0.13 | 0.12 | 0.12 | 0.12 | 0.11 |
| Inventory turnover | 1.25 | 1.24 | 1.19 | 1.22 | 1.17 | 1.09 | 1.05 | 0.93 | 0.91 | 0.78 |
| Days sales outstanding | 242d | 237d | 249d | 298d | 244d | 254d | 287d | 252d | 256d | 293d |
| Days inventory outstanding | 292d | 295d | 307d | 300d | 312d | 335d | 346d | 394d | 400d | 468d |
| Days payable outstanding | 124d | 138d | 144d | 145d | 114d | 114d | 129d | 127d | 143d | 188d |
| Cash conversion cycle | 410d | 393d | 411d | 453d | 441d | 474d | 504d | 519d | 513d | 573d |
| Valuation | ||||||||||
| P / E | 129.3x | 127.5x | 134.2x | 155.2x | 117.5x | 160.6x | 179.9x | 154.8x | 189.2x | 173.9x |
| P / B | 3.5x | 3.5x | 3.4x | 3.4x | 3.2x | 3.6x | 3.5x | 3.4x | 3.6x | 3.2x |
| P / S | 16.7x | 16.7x | 17.1x | 17.6x | 14.8x | 18.1x | 17.4x | 15.7x | 16.3x | 16.7x |
| EV / EBITDA | - | - | 69.4x | 81.3x | - | - | 77.2x | - | - | 73.8x |
| Growth | ||||||||||
| Revenue growth (YoY) | 9.2% | 9.9% | 8.7% | -0.4% | -1.8% | -1.0% | 11.1% | 14.8% | 11.8% | 19.4% |
| Revenue CAGR (3y) | 7.2% | 6.7% | 6.4% | 9.7% | 4.3% | 3.5% | 24.3% | 19.9% | 21.1% | 18.4% |
| Revenue CAGR (5y) | 13.1% | 14.1% | 15.8% | 12.9% | 12.1% | 12.5% | - | - | - | - |
| Gross profit growth (YoY) | 7.4% | 11.6% | 9.7% | -0.2% | 1.3% | -2.5% | 10.7% | 15.6% | 11.5% | 21.5% |
| Operating income growth (YoY) | 11.4% | 21.0% | 32.6% | -1.8% | 13.5% | 18.2% | 19.2% | 13.3% | - | 1005.8% |
| Net income growth (YoY) | 11.2% | 27.9% | 22.0% | 17.7% | 23.3% | 30.1% | 11.0% | 13.7% | - | - |
| EPS growth (YoY) | 12.0% | 28.5% | 22.6% | 16.8% | 23.2% | 30.2% | 13.6% | 14.5% | - | - |
| EPS CAGR (3y) | 16.5% | - | 17.6% | - | 7.2% | 29.8% | 6.7% | 2.2% | -1.9% | 3.6% |
| EPS CAGR (5y) | 8.1% | 9.5% | 11.7% | 8.1% | 7.3% | 6.3% | - | - | - | - |
| FCF growth (YoY) | - | - | 66.8% | -8.8% | - | - | 85.2% | - | - | 182.3% |
| FCF CAGR (5y) | - | - | 37.2% | 21.8% | - | - | - | - | - | - |
| Book value growth (YoY) | 11.5% | 6.3% | 5.4% | 4.8% | 0.0% | 6.7% | 3.7% | 6.2% | 6.5% | -7.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-03-31.
Business segments
$5.94B totalHealthcare Segment$4.21B · 70.9%
Applied Sterilization Technologies$1.14B · 19.2%
Life Science Member$588.80M · 9.9%
Product / service
$10.14B totalProduct$3.06B · 30.2%
Service$2.88B · 28.3%
Servicerevenues$1.62B · 15.9%
Consumablerevenues$1.50B · 14.8%
Capitalequipmentrevenues$1.10B · 10.8%
Geographic
$5.94B totalUS$4.33B · 73.0%
Otherforeignlocations$1.49B · 25.2%
IE$108.50M · 1.8%
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing STERIS plc against the 5 most active filers in the same SIC group.
Dividends
$1.83/share trailing 12 months · -17.9% YoY
| Ex-date | Per share |
|---|---|
| Feb 17, 2026 | $0.6300 |
| Sep 4, 2025 | $0.6300 |
| Jun 10, 2025 | $0.5700 |
| Feb 20, 2025 | $0.5700 |
| Nov 19, 2024 | $0.5700 |
| Sep 5, 2024 | $0.5700 |
| Jun 12, 2024 | $0.5200 |
| Feb 22, 2024 | $0.5200 |
| Nov 20, 2023 | $0.5200 |
| Sep 5, 2023 | $0.5200 |
| Jun 13, 2023 | $0.4700 |
| Feb 23, 2023 | $0.4700 |
| Nov 21, 2022 | $0.4700 |
| Sep 6, 2022 | $0.4700 |
| Jun 13, 2022 | $0.4300 |
| Feb 24, 2022 | $0.4300 |
| Nov 22, 2021 | $0.4300 |
| Sep 2, 2021 | $0.4300 |
| May 27, 2021 | $0.4000 |
| Feb 23, 2021 | $0.4000 |
| Nov 23, 2020 | $0.4000 |
| Aug 26, 2020 | $0.4000 |
| Jun 11, 2020 | $0.3700 |
| Feb 24, 2020 | $0.3700 |